Literature DB >> 23038803

Genetic and antigenic characterization of invasive endemic serogroup B Neisseria meningitidis from Ontario, Canada, in 2001-2010.

Frances B Jamieson1,2, Prasad Rawte2, Shelley L Deeks3,4, Jianwei Zhou5, Dennis K S Law5, Saul Deng5, Raymond S W Tsang5.   

Abstract

This study examined the antigenic and genetic diversity of serogroup B Neisseria meningitidis (MenB) recovered from invasive meningococcal disease (IMD) cases in Ontario, Canada, over the period 2001-2010 during which no MenB outbreaks had occurred. MenB was found to be responsible for 39 % of all IMD cases, with the remaining cases caused mainly by serogroups Y (28 %), C (23.5 %) and W135 (8 %). One hundred and ninety-three individual MenB case isolates were collected and characterized. Of the 88 sequence types (STs) identified, 75 were grouped into 14 known clonal complexes (CCs), whilst 13 STs were not assigned to any known CC. Fifty-seven different PorA genotypes and 88 STs defined the diversity of invasive MenB in Ontario, which supported the endemic nature of MenB disease in Ontario. Despite the presence of the hypervirulent ST-41/44 and ST-32 CCs, no single ST was predominant and responsible for a large number of IMD cases. Although the Québec outbreak clone of ST-269 was also found in Ontario, the 20 case isolates were genetically diverse: they grouped into seven STs and did not have a predominant PorA genotype. eburst analysis identified a new CC responsible for 14.5 % of the MenB case isolates. The six most common PorA variable region 2 (VR2) genotypes (VR2-9, -4, -14, -16, -13-1 and -16-3) were found in 67 % of invasive MenB isolates.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23038803     DOI: 10.1099/jmm.0.050369-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  8 in total

1.  Increase in Neisseria meningitidis serogroup W invasive disease in Canada: 2009-2016.

Authors:  Rsw Tsang; L Hoang; G J Tyrrell; G Horsman; P Van Caeseele; F Jamieson; B Lefebvre; D Haldane; R R Gad; G J German; G Zahariadis
Journal:  Can Commun Dis Rep       Date:  2017-07-06

2.  Increase in ST-11 serogroup W Neisseria meningitidis invasive meningococcal disease in Canada, 2016-2018.

Authors:  R S Tsang; L Hoang; G J Tyrrell; J Minion; P Van Caeseele; J V Kus; B Lefebvre; D Haldane; R Garceau; G German; G Zahariadis; B Hanley
Journal:  Can Commun Dis Rep       Date:  2019-06-06

3.  Homologous recombination drives both sequence diversity and gene content variation in Neisseria meningitidis.

Authors:  Ying Kong; Jennifer H Ma; Keisha Warren; Raymond S W Tsang; Donald E Low; Frances B Jamieson; David C Alexander; Weilong Hao
Journal:  Genome Biol Evol       Date:  2013       Impact factor: 3.416

4.  Diversity of meningococci associated with invasive meningococcal disease in the Republic of Ireland over a 19 year period, 1996-2015.

Authors:  Désirée E Bennett; Kenneth L Meyler; Mary T Cafferkey; Robert J Cunney
Journal:  PLoS One       Date:  2020-02-13       Impact factor: 3.240

5.  Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B Neisseria meningitidis Strains and Their Predicted Coverage by the 4CMenB Vaccine.

Authors:  Raymond S W Tsang; Dennis K S Law; Rosita De Paola; Maria Giuliani; Maria Stella; Jianwei Zhou; Saul Deng; Giuseppe Boccadifuoco; Marzia Monica Giuliani; Laura Serino
Journal:  mSphere       Date:  2020-03-04       Impact factor: 4.389

6.  Invasive serogroup W Neisseria meningitidis (MenW) in Ontario, Canada shows potential clonal replacement during the period January 1, 2009 to June 30, 2016.

Authors:  R S Tsang; S L Deeks; K Wong; A Marchand-Austin; F B Jamieson
Journal:  Can Commun Dis Rep       Date:  2016-12-01

7.  Enhanced surveillance of invasive meningococcal disease in Canada, 2006-2011.

Authors:  Y A Li; R Tsang; S Desai; H Deehan
Journal:  Can Commun Dis Rep       Date:  2014-05-01

8.  Characterization of invasive Neisseria meningitidis from Atlantic Canada, 2009 to 2013: With special reference to the nonpolysaccharide vaccine targets (PorA, factor H binding protein, Neisseria heparin-binding antigen and Neisseria adhesin A).

Authors:  Raymond Sw Tsang; Dennis Ks Law; Rita R Gad; Tim Mailman; Gregory German; Robert Needle
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 Nov-Dec       Impact factor: 2.471

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.